Kestra Medical Technologies Files 8-K on Financials

Ticker: KMTS · Form: 8-K · Filed: Jul 15, 2025 · CIK: 1877184

Kestra Medical Technologies, LTD. 8-K Filing Summary
FieldDetail
CompanyKestra Medical Technologies, LTD. (KMTS)
Form Type8-K
Filed DateJul 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

KESTRA MEDICAL TECHNOLOGIES filed an 8-K on 7/15/25 detailing financial results.

AI Summary

Kestra Medical Technologies, Ltd. filed an 8-K on July 15, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Kirkland, Washington.

Why It Matters

This 8-K filing provides investors with crucial updates on Kestra Medical Technologies' financial performance and operational status.

Risk Assessment

Risk Level: low — This is a routine filing reporting financial information and does not indicate any immediate operational or financial distress.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Kestra Medical Technologies, Ltd., and to include financial statements and exhibits.

When was this 8-K report filed?

This 8-K report was filed on July 15, 2025.

Where are Kestra Medical Technologies' principal executive offices located?

Kestra Medical Technologies' principal executive offices are located at 3933 Lake Washington Blvd NE, Suite 200, Kirkland, Washington, 98033.

What is Kestra Medical Technologies' Standard Industrial Classification code?

Kestra Medical Technologies' Standard Industrial Classification code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What is the company's fiscal year end?

The company's fiscal year end is April 30 (0430).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing